Cancer patients face dangerous choice: blood clots vs. bleeding risk
NCT ID NCT05255003
Summary
This study aims to find the safest way to treat blood clots in cancer patients who also have low platelet counts, which increases their risk of dangerous bleeding. Fifty patients will be randomly assigned to receive either a full dose of blood thinners with platelet transfusions or a reduced dose of blood thinners alone. The goal of this pilot study is to see if a larger, definitive trial is possible to determine the best treatment strategy for these high-risk patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Niagara Health - St. Catharines Site
RECRUITINGSaint Catharines, Ontario, Canada
Contact
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Alberta
WITHDRAWNEdmonton, Alberta, Canada
-
Windsor Regional Hospital
RECRUITINGWindsor, Ontario, N8W 1L9, Canada
Contact
Conditions
Explore the condition pages connected to this study.